Pulmonary arterial hypertension and flavonoids: A role in treatment
Pulmonary arterial hypertension (PAH) is a high mortality progressive pulmonary vascular disease that can lead to right heart failure. The use of clinical drugs for the treatment of PAH is limited to a great extent because of its single target and high price. Flavonoids are widely distributed in nat...
Main Authors: | Jialing Wang, Hailong Li, Tian Xia, Jun Feng, Ru Zhou |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2021-01-01
|
Series: | Chinese Journal of Physiology |
Subjects: | |
Online Access: | http://www.cjphysiology.org/article.asp?issn=0304-4920;year=2021;volume=64;issue=3;spage=115;epage=124;aulast=Wang |
Similar Items
-
Pulmonary arterial hypertension: diagnosis and treatment
by: Marcin Sadowski, et al.
Published: (2013-10-01) -
CURRENT RECOMMENDATIONS ON DIAGNOSIS AND TREATMENT OF PULMONARY ARTERIAL HYPERTENSION
by: S N Avdeev
Published: (2012-04-01) -
Endothelin receptor antagonist bosentan role in modern strategy for patients with pulmonary arterial hypertension treatment
by: O A Arkhipova, et al.
Published: (2018-06-01) -
Endothelin receptor antagonist bosentan role in modern strategy for patients with pulmonary arterial hypertension treatment
by: Arkhipova O.A., et al.
Published: (2018-05-01) -
Fatal dissection of the pulmonary artery in pulmonary arterial hypertension
by: B. Degano, et al.
Published: (2009-09-01)